Profile picture

Mr Mauro Trincado Ave

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
Follow
Logo ESC

Contributor content

Joint relevance of CYP2D6 and H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study.
Presentation
Joint relevance of CYP2D6 and H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study.
Read more
H558R: a common polymorphism may modify the efficacy and toxicity of flecainide in maintaining sinus rhythm; a cohort study.
Presentation
H558R: a common polymorphism may modify the efficacy and toxicity of flecainide in maintaining sinus rhythm; a cohort study.
Read more
Do CYP2D6 polymorphisms affect the efficacy and toxicity of flecainide? A cohort study.
Presentation
Do CYP2D6 polymorphisms affect the efficacy and toxicity of flecainide? A cohort study.
Read more

ESC 365 is supported by

novartis Explore sponsored resources